Communiqués CanadaBis Capital Inc.

Actions

CANB

CA13530Q1046

Installations et services en soins de santé

Temps Différé Toronto S.E. 15:30:00 09/04/2026			Varia. 5j.	Varia. 1 janv.
0,0150 ^CAD	+50,00%		-.--%	-50,00%

30/03	CanadaBis Capital Inc. annonce un report de la publication de ses états financiers pour la période close le 31 janvier 2026	CI
13/02	CanadaBis Capital Inc. annonce le départ de Barb O'Neill du conseil d'administration et du poste de secrétaire générale	CI

Communiqués

10/04	Canadian Investment Regulatory Organization Trading Halt - CANB	AQ
28/03	CANADABIS ANNOUNCES DELAY IN FILING OF SECOND QUARTER FINANCIAL STATEMENTS	AQ
13/02	CANADABIS CAPITAL ANNOUNCES RESULTS OF SHAREHOLDERS MEETING	AQ
31/12	CanadaBis Reports Fiscal Q1 2026 Results with Positive Operating Cash Flow	AQ
10/12	CANADABIS CAPITAL PROPOSES REDUCTION TO CONVERTIBLE DEBENTURE CONVERSION PRICE AND ANNOUNCES INTENTION TO PAY NEXT INSTALLMENT DEBENTURE INTEREST IN COMMON SHARES	AQ
28/11	Canadabis Capital Inc. Announces 2025 Fiscal Year Financial Results	AQ
02/07/25	CanadaBis Capital With its wholly owned Sub. (STIGMA GROW) Announces Revenue Q3 F2025 Resulting in Positve Adjusted EBITDA of $440,665.00 with Gross sales of $5.5 Million as well as 6% increase in Gross Earnings over the prior periods	AQ
29/04/25	Canadian Investment Regulatory Organization Trade Resumption - CANB	AQ
28/04/25	Arrangement Agreement Between CanadaBis Capital and Simply Solventless Inc. Terminated	AQ
28/04/25	Canadian Investment Regulatory Organization Trading Halt - CANB	AQ
14/04/25	CANADABIS ANNOUNCES CLOSING OF FINANCING	AQ
03/04/25	CANADABIS ANNOUNCES CLOSING OF FIRST TRANCHE OF FINANCING FOR $2.6 MILLION	AQ
31/03/25	CanadaBis Capital With its wholly owned Sub. (STIGMA GROW) Announces Revenue Q2 F2025 Resulting in $9M Gross with $96k in NET Earnings and an Adjusted EBITDA of $434,158.00	AQ
28/03/25	CANADABIS ANNOUNCES UPSIZE OF CONVERTIBLE DEBENTURE FINANCING TO $4.5 MILLION	AQ
12/03/25	SIMPLY SOLVENTLESS ANNOUNCES HIGHLY ACCRETIVE ALL SHARE DEAL TO ACQUIRE CANADABIS (STIGMA GROW), CREATING #2 CONCENTRATES AND #5 PREROLL PRODUCER, AND CANADABIS ANNOUNCES $2.5 MILLION CONVERTIBLE DEBENTURE FINANCING	AQ
21/01/25	CanadaBis Capital announces the appointment of Mr. Shane Chana as Chief Financial Officer	AQ
14/01/25	Canadabis Capital Celebrates Historic Milestone: First Shipment of Stigma Grow Products to Portugal	AQ
31/12/24	CanadaBis Capital With its wholly owned Sub. (STIGMA GROW) Announces Record Revenue Q1 F2025 Resulting in $9.6M Gross with $321,569 in NET Earnings and an Adjusted EBITDA of $675,892	AQ
28/11/24	CanadaBis Capital Reports Positive Net Income and Strong Financial Performance for Fiscal Year End 2024	AQ
26/06/24	CANADABIS CAPITAL REPORTS STRONG FINANCIAL RESULTS FOR Q3 2024	AQ
07/05/24	Canadabis Capital Expands into European Market with EU-GMP Partners	AQ
23/04/24	Canadabis Capital Unveils New 60%+ Double-Infused Pre-Roll under Dab Bods Brand, Setting New Standard for THC Potency in Canadian Market	AQ
01/04/24	Canadian Investment Regulatory Organization Trade Resumption - CANB	AQ
01/04/24	CANADABIS CAPITAL CONFIRMS NO MATERIAL CHANGE	AQ
01/04/24	CANADABIS CAPITAL, WITH SUB STIGMA GROW, ANNOUNCES FISCAL Q2 2024 RESULTS HIGHLIGHTED BY CONTINUED POSITIVE ADJUSTED EBITDA(1) AND NET INCOME	AQ